|
|
Volumn 69, Issue 3, 2008, Pages 185-192
|
|
Switch of ESA therapy from darbepoetin-α to epoetin-β in hemodialysis patients: A single-center experience
a
|
|
Author keywords
Darbepoetin ; Epoetin ; ESA dose; ESA treatment switch; Hemodialysis; Hemoglobin
|
|
Indexed keywords
ANALGESIC AGENT;
ANGIOTENSIN RECEPTOR ANTAGONIST;
CALCINEURIN INHIBITOR;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FERROUS GLUCONATE;
HEMOGLOBIN;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
RECOMBINANT ERYTHROPOIETIN;
ADULT;
AGED;
ANEMIA;
ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SUBSTITUTION;
ERYTHROCYTE TRANSFUSION;
FEMALE;
HEMODIALYSIS PATIENT;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
KIDNEY DISEASE;
MAJOR CLINICAL STUDY;
MALE;
RETROSPECTIVE STUDY;
UNSPECIFIED SIDE EFFECT;
|
|
EID: 40449104746
PISSN: 03010430
EISSN: None
Source Type: Journal
DOI: 10.5414/cnp69185 Document Type: Article |
|
Times cited : (8)
|
|
References (44)
|
